A Pilot Study Investigating the Effect of Pembrolizumab on the Tumoral Immunoprofile of Cancers of Muellerian Origin

Research Grant

Duke Scholars

Principal Investigator Angeles Alvarez Secord Obstetrics and Gynecology, Gynecologic Oncology

Administered By

Duke Cancer Institute

Awarded By

Merck Sharp & Dohme

Start Date

May 1, 2016

End Date

October 31, 2022

Administered By

Duke Cancer Institute

Awarded By

Merck Sharp & Dohme

Start Date

May 1, 2016

End Date

October 31, 2022